Physician profile
Robert J Miles
NPI 1194161778
$3,681.83
in general payments reported to CMS, 2019-2025
33 companies · $767 in 2025
The $767 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $87.78 · 2021: $729 · 2022: $971 · 2023: $779 · 2024: $200 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,746.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $886.17 | 2021-2024 | Jardiance, Stiolto Respimat |
| Aop Health US, LLC | $508.58 | 2025 | Rapiblyk |
| Novartis Pharmaceuticals Corporation | $425.55 | 2019-2023 | |
| Boston Scientific Corporation | $302.65 | 2021-2023 | Watchman Access System |
| Pfizer INC. | $149.45 | 2019-2023 | |
| Amgen INC. | $135.25 | 2020-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $124.33 | 2021-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $123.13 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $108.70 | 2021-2024 | Xarelto |
| Amarin Pharma, INC. | $88.58 | 2021-2022 | |
| Daiichi Sankyo INC. | $87.57 | 2020-2023 | Injectafer |
| Vital Connect, INC | $75.78 | 2023-2025 | Vitalpatch Rtm |
| Stryker Corporation | $71.39 | 2025 | Flowtriever |
| Bayer Healthcare Pharmaceuticals INC. | $63.98 | 2021-2022 | |
| Merz North America, INC. | $63.19 | 2023 | Xeomin |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $62.50 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $55.05 | 2020-2025 | Wainua |
| Astellas Pharma US INC | $51.67 | 2021 | |
| Solventum Corporation | $38.64 | 2024-2025 | V.A.C.Instill, Activ.A.C., Prevena |
| Cardiva Medical, INC. | $30.30 | 2022 | |
| Convatec INC. | $26.75 | 2025 | |
| Abbott Laboratories | $26.07 | 2024 | Cardiomems |
| Angiodynamics, INC. | $20.90 | 2023 | Auryon Laser System 100-120 Vac |
| Cardiovascular Systems INC. | $18.80 | 2021 | |
| Cvrx, INC. | $16.98 | 2023 | Barostim Neo System |
| Teleflex LLC | $16.81 | 2023 | Turnpike |
| Esperion Therapeutics, INC. | $16.25 | 2023 | Nexletol |
| Philips North America LLC | $15.83 | 2022 | |
| Abiomed | $15.50 | 2025 | |
| Bardy Diagnostics, INC. | $15.00 | 2020 | |
| Baxter Healthcare | $14.82 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Bracco Diagnostics INC. | $13.68 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.